Trailing-twelve-month (TTM) revenue is $2.03 Billion with a year-over-year growth of +7.84%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $487,330,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2026-01-03 | $503,411,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-04 |
| Q1 FY2026Period ended 2026-04-04 | $543,880,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-07-04 | $498,805,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $2,033,426,000 |
Current P/S: $1,344,358,226 market capitalization ÷ $2,033,426,000 TTM revenue = 0.66x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:40:23.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $498.81M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:42:01.619Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Accessories And Other | N/A | N/A | N/A | $8M | $10M | $11M |
| Contact Lenses | N/A | N/A |
$2.03B
$2.03 Billion
+7.84%
vs. $1.89B a year ago (TTM)
(0.31%)
5 Year compound annual growth rate
1 Year
+7.84%
3 Year
+1.91%
5 Year
(0.31%)
10 Year
+6.46%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.99B | +$164.17M | +9.00% |
| 2024 | $1.82B | ($303.15M) | (14.26%) |
| 2023 | $2.13B | +$481.79M | +29.29% |
| 2022 | $1.64B | ($434.85M) | (20.91%) |
| 2021 | $2.08B | +$367.76M | +21.48% |
| 2020 |
TTM Growth
+7.84%
3-Year CAGR
+1.91%
5-Year CAGR
(0.31%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:42:01.619Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $543M |
| $307M |
| $324M |
| Eyeglasses And Sunglasses | N/A | N/A | N/A | $1.2B | $1.1B | $1.3B |
|---|
| Product Sales | $1.4B | $1.7B | $1.6B | $1.7B | $1.5B | $1.6B |
|---|
| Services And Plans | $293M | $361M | $357M | N/A | $360M | $383M |
|---|
| $1.71B |
| ($12.57M) |
| (0.73%) |
| 2019 | $1.72B | +$187.48M | +12.20% |
| 2018 | $1.54B | +$161.55M | +11.75% |
| 2017 | $1.38B | +$179.11M | +14.97% |
| 2016 | $1.20B | +$133.67M | +12.58% |
